DOI:
10.1055/s-00000099
Zeitschrift für Orthopädie und Unfallchirurgie
LinksClose Window
References
Schöffski P, Chawla S, Maki RG. et al.
Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial.
Lancet 2016;
387: 1629-1637
We do not assume any responsibility for the contents of the web pages of other providers.